IP 173 (Memantine Hydrochloride 5 mg)
Pill with imprint IP 173 is Orange, Rectangle and has been identified as Memantine Hydrochloride 5 mg. It is supplied by Amneal Pharmaceuticals of New York, LLC.
Memantine is used in the treatment of alzheimer's disease and belongs to the drug class miscellaneous central nervous system agents. There is no proven risk in humans during pregnancy. Memantine 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for IP 173
Memantine Hydrochloride
- Imprint
- IP 173
- Strength
- 5 mg
- Color
- Orange
- Shape
- Rectangle
- Availability
- Prescription only
- Drug Class
- Miscellaneous central nervous system agents
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals of New York, LLC
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
magnesium stearate,
microcrystalline cellulose,
magnesium silicate,
D&C Yellow No. 10,
FD&C Blue No. 2,
FD&C Yellow No. 6,
polyethylene glycol,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 53746-0173 | Amneal Pharmaceuticals LLC |
| 42291-0551 (Discontinued) | AvKare, Inc. |
Related images for "IP 173"
More about memantine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (64)
- Drug images
- Pricing & coupons
- En español
- Drug class: miscellaneous central nervous system agents
Patient resources
- Drug Information
- Memantine (Advanced Reading)
- Memantine Extended-Release Capsules
- Memantine Tablets
- Memantine Solution
- Other brands
- Namenda, Namenda XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.